カテゴリ： MarketLine, フランス, 企業調査

Allianz France S.A.：企業の戦略・SWOT・財務情報

◆英語タイトル：Allianz France S.A. - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C13874
◆発行会社（調査会社）：MarketLine
◆発行日：2019年2月
◆ページ数：26
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：フランス
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Allianz France S.A. – Strategy, SWOT and Corporate Finance Report
Summary

Allianz France S.A. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Allianz France S.A. (Allianz France), a subsidiary of Allianz SE, is a provider of insurance products to individuals and businesses. The company offers a range of individual and business insurance products. It offers insurance products for car, two wheels, home, home loan, housing equipment, recreation, health, family, legal, dog, and life. It also offers commercial vehicle insurance, commercial property insurance, event insurance, public liability insurance, cyber risk insurance, group health insurance, and key persons insurance. The company serves individuals, professionals, startups, associations, and enterprises. The company markets and distributes its products through agents, advisors and broker partners. Allianz France is headquartered in Paris, France.

Scope

- Detailed information on Allianz France S.A. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Allianz France S.A. in the form of a SWOT analysis
- An in-depth view of the business model of Allianz France S.A. including a breakdown and examination of key business segments
- Intelligence on Allianz France S.A.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Allianz France S.A., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Allianz France S.A. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Allianz France S.A. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Allianz France S.A.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Allianz France S.A.: Company Overview
Allianz France S.A.: Overview and Key Facts
Allianz France S.A.: Overview
Allianz France S.A.: Key Facts
Allianz France S.A.: Key Employees
Allianz France S.A.: Major Products and Services
Allianz France S.A.: Company History
Allianz France S.A.: Locations and Subsidiaries
Allianz France S.A.: Key Competitors
Allianz France S.A.: Company Analysis
Allianz France S.A.: Business Description
Allianz France S.A.: SWOT Analysis
Allianz France S.A.: SWOT Overview
Allianz France S.A.: Strengths
Allianz France S.A.: Weaknesses
Allianz France S.A.: Opportunities
Allianz France S.A.: Threats
Allianz France S.A.: Recent Developments
Allianz France S.A.: News and Events Summary
Allianz France S.A.: Business Expansion
Allianz France S.A.: Contracts
Allianz France S.A.: Corporate Governance
Allianz France S.A.: Financial Deals
Allianz France S.A.: Financial Performance
Allianz France S.A.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Allianz France S.A.: Key Facts
Table 2: Allianz France S.A.: Key Employees
Table 3: Allianz France S.A.: Company History
Table 4: Allianz France S.A.: Locations and Subsidiaries
Table 5: Allianz France S.A.: Key Competitors
Table 6: Allianz France S.A.: News and Events Summary
Table 7: Allianz France S.A.: Business Expansion
Table 8: Allianz France S.A.: Contracts
Table 9: Allianz France S.A.: Corporate Governance
Table 10: Allianz France S.A.: Financial Deals
Table 11: Allianz France S.A.: Financial Performance
Table 12: Allianz France S.A.: Strategy and Operations



★海外企業調査レポート[Allianz France S.A.：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Resona Holdings, Inc.：企業の戦略・SWOT・財務情報
    Resona Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Resona Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Kuwait Food Company (Americana) KSCP：企業の戦略的SWOT分析
    Kuwait Food Company (Americana) KSCP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Silex Systems Ltd (SLX)：企業の財務・戦略的SWOT分析
    Summary Silex Systems Ltd (Silex) is a research and development company that offers technology solutions. The company develops, and commercializes technologies in solar energy, nuclear energy, and advanced materials and instrumentation. It develops utility-scale concentrating photovoltaic technology …
  • NBE-Therapeutics AG：製薬・医療：M&Aディール及び事業提携情報
    Summary NBE-Therapeutics AG (NBE-Therapeutics) is a biotechnology company that focuses on the development of antibody drug conjugates (ADC) to improve the treatment of cancer. ADCs act against cancer cells via tumor-specific antibodies and deliver powerful cellular toxins to such cancer cells. The c …
  • Cleveland BioLabs, Inc.：企業のM&A・事業提携・投資動向
    Cleveland BioLabs, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cleveland BioLabs, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Sysco Corporation：企業の戦略・SWOT・財務情報
    Sysco Corporation - Strategy, SWOT and Corporate Finance Report Summary Sysco Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Prescient Therapeutics Ltd (PTX)：企業の財務・戦略的SWOT分析
    Summary Prescient Therapeutics Ltd (Prescient Therapeutics), formerly Virax Holdings Ltd, is a clinical stage oncology company that develops novel drugs for the treatment of solid and hematological cancers. The company’s lead drug candidate includes PTX-200, a potent small molecule inhibitor of the …
  • Green Highland Renewables Ltd：電力：M&Aディール及び事業提携情報
    Summary Green Highland Renewables Ltd (GHRL), formerly Green Highlander Renewables Limited, a subsidiary of Ancala Partners LLP, is a renewable energy company that develops, builds, and maintains hydro electric schemes. The company provides services including site identification, environmental appra …
  • Trican Well Service Ltd (TCW)：石油・ガス：M&Aディール及び事業提携情報
    Summary Trican Well Service Ltd (Trican) is an oilfield services company, which provides specialized products, equipment, services and technology for use in the drilling, completion, stimulation and reworking of oil and gas wells. Its specialized services comprise fracturing, cementing, coiled tubin …
  • Progenics Pharmaceuticals, Inc.：企業の戦略・SWOT・財務分析
    Progenics Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Progenics Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Melinta Therapeutics Inc (MLNT)：企業の財務・戦略的SWOT分析
    Melinta Therapeutics Inc (MLNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Star Gas Partners L.P.
    Star Gas Partners L.P. - Strategy, SWOT and Corporate Finance Report Summary Star Gas Partners L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Church & Dwight Co Inc：企業のM&A・事業提携・投資動向
    Church & Dwight Co Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Church & Dwight Co Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Delegat’s Group Limited：戦略・SWOT・企業財務分析
    Delegat's Group Limited - Strategy, SWOT and Corporate Finance Report Summary Delegat's Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Echo Therapeutics Inc (ECTE)-医療機器分野：企業M&A・提携分析
    Summary Echo Therapeutics Inc (Echo Therapeutics) is a medical device and a specialty pharmaceutical company, which develops wireless continuous glucose monitoring (CGM) system. Its product portfolio includes Continuous Glucose Monitoring, which is a CGM System, a skin preparation device, transderma …
  • Paymark：企業の戦略的SWOT分析
    Paymark - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Invenergy LLC：企業の発電所・SWOT分析2018
    Invenergy LLC - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exec …
  • Skinvisible Pharmaceuticals Inc-製薬・医療分野：企業M&A・提携分析
    Summary Skinvisible Pharmaceuticals Inc (Skinvisible Pharmaceuticals), a subsidiary of Skinvisible Inc is a pharmaceutical company that develops and manufactures prescription and over the counter dermatology, medical, cosmetic, consumer goods, and skincare products. The company’s products include an …
  • Jardine Matheson Holdings Limited：戦略・SWOT・企業財務分析
    Jardine Matheson Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Jardine Matheson Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Biocodex Inc-製薬・医療分野：企業M&A・提携分析
    Summary Biocodex Inc (Biocodex), a subsidiary of Biocodex is a manufacturer and distributor probiotic drug products. The company’s products include Saccharomyces boulardii CNCM I-745 that has a positive effect on the gut's microflora. It also provides Florastor, a yeast-based probiotic that helps ke …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆